China Pharma Holdings (CPHI) Current Assets (2010 - 2026)

China Pharma Holdings (CPHI) has reported Current Assets for 17 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets fell 25.7% year-over-year to $2.0 million; the trailing twelve-month figure through Jun 2026 stood at $2.0 million (down 25.7% YoY), and the FY2025 full-year result was $2.3 million, down 28.25% from the prior year.
• Current Assets held at $2.0 million in Q2 2026 per CPHI's latest filing, from $2.0 million in the prior quarter.
• Across five years, Current Assets topped out at $8.2 million in Q1 2022 and bottomed at $2.0 million in Q1 2026.
• Historically, Current Assets has averaged $4.4 million across 5 years, with a median of $4.5 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Current Assets surged 67.22% in 2022, then sank 45.47% in 2024.
• Over 5 years, Current Assets stood at $6.0 million in 2022, then rose by 0.54% to $6.0 million in 2023, then slumped by 45.47% to $3.3 million in 2024, then slipped by 28.25% to $2.3 million in 2025, then slipped by 14.48% to $2.0 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $2.0 million, $2.0 million, and $2.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.